Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma

Published:2024-06 Issue:2 Volume:32 Page:200817
ISSN:2950-3299
Container-title:Molecular Therapy: Oncology
language:en
Short-container-title:Molecular Therapy: Oncology

Author:

Zhou Linfu,Li Yao,Zheng Diwei,Zheng Yongfang,Cui Yuanbin,Qin Le,Tang Zhaoyang,Peng Dongdong,Wu Qiting,Long Youguo,Yao Yao,Wong Nathalie,Lau James,Li Peng^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference60 articles.

1. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Prim.,2016

2. Hepatocellular carcinoma;Forner;Lancet,2018

3. The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels;Yang;Cancer Med.,2022

4. Clinical value of identifying genes that inhibit hepatocellular carcinomas;Testa;Expert Rev. Mol. Diagn.,2022

5. Molecular therapies and precision medicine for hepatocellular carcinoma;Llovet;Nat. Rev. Clin. Oncol.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP